TIME TO REVISIT UNEVEN POLICY IN THE UNITED STATES FOR MEDICATION FOR OPIOID USE DISORDER DURING COVID-19.

Pena, Eduardo; Ahmed, Saeed

Pena, Eduardo; Ahmed, Saeed.

Pena E; Drug Dependence Treatment Center, VA Boston Healthcare System, Jamaica, Plain, MA, USA.
Ahmed S; Boston Medical Center/VA Boston Healthcare System, Boston, MA, USA.

Addiction ; 115(10): 1978-1979, 2020 10.

Article in English | MEDLINE | ID: covidwho-811012

Subject(s)

Analgesics, Opioid/therapeutic use; Coronavirus Infections/prevention & control; Narcotic Antagonists/therapeutic use; Opiate Substitution Treatment/methods; Opioid-Related Disorders/drug therapy; Pandemics/prevention & control; Physical Examination; Pneumonia, Viral/prevention & control; Betacoronavirus; Buprenorphine/therapeutic use; COVID-19; Humans; Methadone/therapeutic use; Practice Guidelines as Topic; SARS-CoV-2; United States

Keywords

Buprenorphine/naloxone; Covid-19; MOUD; OTPs; SAMHSA; medication for opioid use disorder; methadone; opioid treatment programs

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Physical Examination / Pneumonia, Viral / Coronavirus Infections / Opiate Substitution Treatment / Pandemics / Analgesics, Opioid / Narcotic Antagonists / Opioid-Related Disorders Type of study: Prognostic study Limits: Humans Country/Region as subject: North America Language: English Journal: Addiction Journal subject: Substance-Related Disorders Year: 2020 Document Type: Article Affiliation country: Add.15143

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google